1. January 2025

Advocacy Impact

An icon representing Advocacy Impact that depicts a microscope, conversation bubble, and document.
A banner advertising Advocacy Brief, ASPET's Science Policy Newsletter. The U.S. Capitol building is shown in the background.

ASPET’s Advocacy Brief Encourages Participation

By Tricia McCarter

The American Society for Pharmacology and Experimental Therapeutics (ASPET) provides several advocacy resources to prepare its members to engage with congressional members. From interacting with the public to communicating with the media, the Society’s advocacy efforts are shaping the science policy conversations regarding pharmacology not only on Capitol Hill but also beyond the halls of Congress.

Now in its second year, ASPET’s science policy newsletter, Advocacy Brief, helps members keep up with breaking news on policy decisions and legislation affecting biomedical research, research funding opportunities, regulations and other important matters impacting pharmacology and pharmacologists.

Advocacy Brief, ASPET’s science policy newsletter, provides up-to-date policy news and information relevant to the scientific, biomedical and research communities. The Society’s government affairs and science policy team work to advance the interests of ASPET members by meeting and advocating for these interests with elected officials and staff. Advocacy Brief is a member benefit that highlights the latest policy, appropriations and other relevant news from Capitol Hill and the federal agencies representing scientists.

The bi-monthly newsletter also offers opportunities for members to provide feedback on policy issues and ASPET’s comments on requests for information from congressional committees. Recently, Advocacy Brief covered several issues, including:

  • NIH’s scientific integrity policy on research integrity;
  • How NIH utilizes AI and other digital technologies to enhance its grants and application management operations;
  • Appropriation hearings on funding levels affecting federal agencies, including NIH;
  • Status updates on political stalemates on Capitol Hill directly affecting scientists;
  • FDA guidance documents that advise the public on the agency’s interpretation of statues and regulations; and
  • ASPET’s comments on re-envisioning postdoctoral research training.

Advocacy Brief is a resource for ASPET members to not only stay informed about science policy issues that affect them, but also to capitalize on opportunities to have their voices and opinions heard. Congressional Requests for Information on topics affecting ASPET members are shared in the newsletter, making this a unique opportunity for members to become involved in influencing policy outcomes that impact their work.

To receive regular issues of Advocacy Brief, join ASPET!

Author

  • Tricia McCarter, CDMP, PCM

    Tricia McCarter, CDMP, PCM, is ASPET’s Senior Coordinator of Marketing and Communications and the Managing Editor of The Pharmacologist. She has more than five years of communications and marketing experience within the non-profit industry. She holds a master’s degree in journalism and a double certification as a Certified Digital Marketing Professional through the Digital Marketing Institute and a Professional Certified Marketer in Digital Marketing through the American Marketing Association.

    View all posts